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Zhaogen Cai and Zenong ChengAbstract
Background: Centrally necrotizing carcinoma of the breast (CNC) represents a newly-identified subset of breast cancer.
The clinical and pathological characteristics of this breast cancer subtype are not yet completely understood.
Methods: We assessed the clinicopathological characteristics of 73 cases of CNC and 30 control cases of high-grade
infiltrating ductal carcinoma (IDC) with focal necrosis based on light microscopy and immunohistochemical staining for
estrogen receptor, progesterone receptor, Cerb-B2/HER2, Ki-67, epidermal growth factor receptor, cytokeratin 5/6, smooth
muscle actin, S-100 protein, p63 and CD10.
Results: All the tumors showed extensive central necrotic or acellular zones with different degrees of fibrotic or
hyaline material surrounded by ring-like or ribbon-like residual tumour tissue which were usually high-grade
IDCs. The central necrotic zone accounted for at least 30% of the cross-sectional area of the tumor. Thirty-six
cases (49.3%) showed a component of ductal carcinoma in situ. The tumorous stroma around the central
necrotic zone was accompanied by myxoid matrix formation in 28 cases (40%). Lymphocytic infiltration was
present in 53 cases (72.6%). Granulomatous reactions were detected at the periphery of the tumors in 49 cases
(67.1%). Immunohistochemistry showed greater expression of basal-like markers (72.2%, 52 cases) than myoepithelial
markers (60.6%, 43 cases), both of which were significantly higher than in controls (26.7%, 8 cases) (P < 0.001). According
to molecular typing, most CNCs were basal-like subtype (37 cases, 50.7%). Follow-up data were available for 28 patients.
Disease progression occurred in 11 patients. The combined rate of recurrence, distant metastasis or death was significantly
higher in CNC patients compared with controls (P < 0.05).
Conclusions: CNC was associated with distinctive clinicopathologic features mostly characterized as basal-like type. Its
high proliferative activity, highly-aggressive biological behavior, and high rates of recurrence and metastasis, suggest that
CNC should be classified as a new type of breast carcinoma.
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Centrally necrotizing carcinoma of the breast (CNC)
represents a newly-identified subset of breast cancer,
usually included in “infiltrating ductal carcinoma, not
otherwise specified”. It has been described as a “fibrotic
focus in invasive ductal carcinoma of the breast” [1], and
as “high-grade invasive ductal carcinomas with large
central acellular zones” [2,3], since its first description
by Jimenez et al. in 2001 [4]. There have only been four* Correspondence: ydh_2210@126.com
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unless otherwise stated.reports of CNC to date; two case reports, and two other
studies [4-7]. The clinical and pathological characteris-
tics of this breast cancer subtype thus remain poorly
understood. We therefore retrospectively analyzed the
clinicopathological features, immunophenotype, and bio-
logical behavior of 73 cases of CNC definitively diag-
nosed in our pathology department, and conducted a
literature review.Methods
Materials
Seventy-three patients with CNC of the breast were ini-
tially diagnosed as infiltrating ductal carcinoma (IDC)This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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of Pathology, First Hospital Affiliated to Bengbu Medical
College. A total of 1,998 breast cancer cases were admit-
ted to our hospital between January 2011 and December
2012, though not all had complete clinical and patho-
logical data. During this period, 54 cases of CNC were
diagnosed in our pathology department, accounting for
2.7% of all breast cancers. Thirty patients with high-
grade IDCs with minimal necrosis (necrotic area <30%
of the cross-sectional area of the tumor) were randomly
selected as controls. The two sets of tumors were
matched for tumor size, nodal status and histologic
grade (P > 0.05) (Table 1). According to the diagnostic
criteria of Tsuda and Jimenez et al. [2,4], CNC met the
following conditions: (i) tumor composed of extensive
central necrosis with varying degrees of fibrotic, hyali-
nized matrix or scar tissue; (ii) necrotic or acellular
zones accounted for ≥30% of the cross-sectional area of
the tumor (necrotic area measured under a microscope,
compared with the total tumor area by microscopic or
gross inspection); (iii) viable tumor tissue was mostly
high-grade IDC (histological grade assessed according to
the WHO-recommended Elston-Ellis Classification of
Breast Carcinoma 2003 edition [8] and modified Scarff-
Bloom-Richardson system [9]).
Methods
Surgical specimens were fixed with 10% neutral buffered
formalin and embedded in paraffin blocks. Tissue blocks
were cut into 4-μm slides, deparaffinized in xylene, rehy-
drated with a graded alcohol series, and immunostained
with the following antibodies: estrogen receptor (ER;
1D5), progesterone receptor (PR; PgR 636), HER2 (Poly-
clone), Ki-67 (MIB-1), epidermal growth factor receptor
(EGFR; EGFR.113), cytokeratin 5/6 (CK5/6; D5/16B4),
smooth muscle actin (SMA; 1A4), S-100 protein (4C4.9),
p63 (4A4) and CD10 (MX002). Sections were stained
using a streptavidin-peroxidase system (KIT-9720, Ultra-
sensitive TM S-P, MaiXin, China). The chromogen used
was diaminobenzidine tetrahydrochloride substrate
(DAB kit, MaiXin, China), and sections were slightlyTable 1 Clinicopathological features in CNC and control
patients
Experimental
group
Control group P
(CNC) (IDC with localized
necrosis)
Mean tumor size
(cm)
2.49 2.34 >0.05
Negative lymph
nodes
40/62 19/30 0.988
IDC grade 3 67/73 27/30 0.771
IDC, infiltrating ductal carcinoma.counterstained with hematoxylin, dehydrated and
mounted. Positive and negative controls were included
for each antibody, according to the kit instructions.
Immunopositivity for ER or PR was defined as >10% of
tumor cells with nuclear immunoreactivity for ER or PR,
respectively. According to the standard guide [10], >10%
tumor cells with membranous staining 3+ for HER2 was
considered as positive expression. More than 5% of tumor
cells with cytoplasmic and/or membranous staining for
CK5/6, SMA and CD10, nuclear reactivity for S-100 pro-
tein and p63, and membranous reactivity for EGFR were
considered to indicate positivity for the respective antigen.
Nuclear Ki-67 immunoreactivity was considered as posi-
tive expression.
Written informed consent for participation in the
study was obtained from participants and accompanying
images. A copy of the written consent is available for re-
view by the Editor-in Chief of this Journal.
Molecular typing
Tumors were divided into five types based on the immuno-
histochemical results and the classification of Carey et al.
[11]: luminal-A (ER+ and/or PR+, HER2−), luminal-B (ER+
and⁄or PR+, HER2+), basal-like (ER−, PR− and HER2−, but
positive for ≥1 basal-like markers), HER2 overexpressing
(ER−, PR−, HER2+), and null phenotype (negative for all
the above markers).
Follow-up data
Follow-up data were obtained by asking patients or their
relatives. Disease-free survival (DFS) was defined as the
period from the first surgery for breast carcinoma to re-
currence, metastasis, death, or the last follow-up. Dis-
ease progression was defined as recurrence, metastasis
or death due to breast carcinoma. Overall survival (OS)
was defined as the period from the first surgery to death
or last follow-up.
Statistical methods
The significance of differences between the CNC and
control groups, and differences within the CNC group
were analyzed by Student’s t-tests for means and χ2 tests
for frequencies. Values of P < 0.05 were considered sta-
tistically significant.
This study was approved by the Ethics Committees of
the First Affiliated Hospital of Bengbu Medical College
and conducted in accordance with the ethical guidelines
of the Declaration of Helsinki.
All the authors read and approved the final manuscript.
Results
Clinical information
All 73 patients were women, with a mean age of
51.8 years (range, 34–80 years). These patients accounted
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during the same period. The clinical genetic testing or
strong family history were not available. Ultrasound exami-
nations were performed in 26 patients, of whom 14 pre-
sented with well-defined, heterogeneous, hypoechoic
lesions (Figure 1a). Mammary gland molybdenum targets
were available in 30 patients, six of whom showed Breast
Imaging Reporting and Data System (BI-RADS) category 4
and 26 of whom showed BI-RADS 5. Well-defined, hetero-
geneous, higher-density shadows were present in 21 cases
(Figure 1b), while blurred or spiculate borders were seen in
nine cases and markedly increased vessels in 18 cases.
Breast-conserving surgery was performed in one patient
(without axillary lymph node dissection) and modified rad-
ical mastectomy in 62 patients, of whom 64.5% (40/62)
were axillary node negative. The remaining 35.5% (22/62)
had axillary lymph node metastases. The numbers of lymph
node metastases were one in five patients, two in six pa-
tients, three in two patients, four in one patient and more
than four in eight patients (mean, 5.8). Follow-up data were
available in 28 patients, with a mean follow-up time of
21.2 months (range, 7.0–40.0 months). The mean and me-
dian DFS were 13.8 and 14.5 months, respectively. Disease
progression occured in 11 patients, including one patient
with regional recurrence in the ipsilateral chest wall and
ten patients with distant metastases (three pulmonary, three
brain, two bone, one liver, and one supraclavicular lymph
nodes and mediastinum). At the time of the last follow-up,
one patient had died of breast carcinoma. There was no
significant relationship between disease progression of
CNC and the relative size of the necrotic zone (P > 0.05).
Follow-up data were available for 11 control patients, with
a mean follow-up time of 31.6 months. No controls had re-
gional recurrence, distant metastasis, or death at the last
follow-up.
Pathological features
The mean tumor diameter was 2.49 cm (range, 1.0–
6.5 cm). Sixty-seven patients (91.8%) had unicentricFigure 1 The imaging features of CNC. (a): Ultrasonography indicated a w
manifested as a irregular nodule with a heterogeneous, higher-density shanodules (Figure 2), two had double nodules (2.7%), and four
had lobulated lesions (5.5%). Most tumors had well-defined
boundaries, but 14 (19.2%) with infiltrative edges. The cut
surface was gray, sallow, or reddish-brown, with necrosis or
cystic degeneration in the central region (Figure 2).
Microscopically, all the tumors presented with an ex-
tensive central necrotic or acellular zones surrounded by
ring-like or ribbon-like residual tumor tissue. The transi-
tion between the central necrotic or acellular zone and
viable tumor tissue was usually abrupt (Figure 3a).
The central necrotic zone varied in size and morph-
ology. The morphological features of the central necrotic
or acellular zone were: (i) coagulative necrosis as the
main feature in 47 cases (63.4%), shown as a pink, fine-
granular area with discernible hemorrhage, necrotic tis-
sue fragments, or ‘ghost’ cells, and scattered or focal
fibrotic or hyaline material (Figure 3b); (ii) fibrotic, hya-
line material or scar tissue occupied most of the central
zone in 24 cases (32.9%), arranged in cords or sheets,
with a small amount of necrotic cellular debris or ‘ghost’
cells; (iii) the remaining two cases (2.7%) consisted of in-
farction without varying degrees of fibrotic or hyaline
material, in which the original outline of organizational
structure could be seen indistinctly.
The residual tumor tissue surrounding the central nec-
rotic zone varied, but most cases showed high-grade
IDCs (67 cases, 91.8%). The tumor cells were arranged
in cord-like or nest-like patterns, lacking tube-like struc-
tures. Most tumor cells showed evident atypia, promin-
ent nucleoli, and frequent mitotic figures (Figure 3c).
Multinucleated giant cells were present in several cases.
A ductal carcinoma in situ component was present in 36
cases (49.3%); five cases (6.8%) were associated with a
mucinous carcinoma component, two with invasive
micropapillary carcinoma, one with intraductal papillary
carcinoma. Focal metaplasia was present in six cases
(8.2%), including squamous metaplasia in four, spindle
cell differentiation in one, and cartilaginous metaplasia
in one (Figure 3d).ell-defined, heterogeneous, hypoechoic lesion. (b): The tumor was
dow, associated with tortuous vasculature around the tumor.
Figure 2 The tumors showed unicentric nodules. The cut surface
had a white to tan appearance, accompanied by necrosis in the
central region.
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zone was accompanied by myxoid matrix formation in
28 cases (40%), lymphocytic infiltrates were present in
53 (72.6%), histiocytic reaction in five, and calcification
in 20 cases.Figure 3 Microscopical findings of CNC. (a): The tumor presented with an
or ribbon-like residual tumor tissue. The transition between the central nec
(b): The central zone of the tumor showed coagulative necrosis with pink, fin
stroma around the central necrotic zone, accompanied by myxoid matrix form
patterns. Most of the tumor cells showed evident atypia, prominent nucleoli,
present in this case (→)(×10). (e): The periphery of the tumors demonstratingThe periphery of the tumor demonstrated a well-
defined boundary in 59 cases (80.8%), including 49 cases
(67.1%) in which the tumor was enclosed by fibers indi-
cating a granulomatous reaction (Figure 3e). The
remaining 14 cases (19.2%) showed poorly-defined
boundaries with infiltrative edges. Vascular invasion was
seen in ten cases (13.7%) and nerve infiltration in five.
There were no significant associations between the clini-
copathological features of CNC and the relative size of
the necrotic zone (P > 0.05) (Table 2).
Immunohistochemical analysis
There was extensive cellular proliferation. The Ki-67-
labeling index was >50% in 62 cases (84.9%), and >70% in
43 cases. Fifty-two tumors (72.2%) expressed one or more
basal-like markers (CK5/6 and EGFR) (Figures 4a, b), and
43 (60.6%) expressed one or more myoepithelial markers
(SMA, S-100, CD10, p63) (Figure 4c); however, 40 of these
43 also expressed basal-like markers. Basal-like and myoe-
pithelial markers were detected in 26.7% and 16.7% of con-
trols, respectively. Basal-like and myoepithelial markers
were expressed significantly more frequently in patients
with CNC compared with controls (P < 0.05). However,
there was no significant association between the expressionextensive central necrotic or acellular zone surrounded by ring-like
rotic or acellular zone and the viable tumor tissue was abrupt (×4).
e granules combined with fibrotic or hyaline material and a tumorous
ation (×10). (c): The tumor cells were arranged in cord-like or nest-like
and frequent mitotic figures (×40). (d): Focal cartilaginous metaplasia was
the granulomatous reaction(→) (×40).
Table 2 Relationship between clinicopathological features and extent of necrosis in 73 patients with CNC
Clinicopathological feature Case ≥30% but <50% necrosis ≥50% but <70% necrosis ≥70% necrosis P
(7, 9.6%) (25, 34.3%) (41, 56.2%)
IDC Grade 3 67 7 (100.0%) 23 (92.0%) 37 (82.2%) 0.685
Grade 2 6 0 (0.0%) 2 (8.0%) 4 (9.8%) 0.685
Grade 1 0 0 (0.0%) 0 (0.0%) 0 (0.0%) —
Ductal carcinoma in situ 36 4 (57.1%) 13 (52.0%) 19 (46.3%) 0.823
Mucinous carcinoma 5 1 (14.3%) 3 (12.0%) 1 (2.4%) 0.235
Intraductal papillary carcinoma 1 0 (0.0%) 0 (0.0%) 1 (2.4%) 0.673
Invasive micropapillary carcinoma 2 0 (0.0%) 1 (4.0%) 1 (2.4%) 0.835
Metaplasia 6 0 (0.0%) 4 (16.0%) 2 (4.9%) 0.198
Myxoid stroma 28 1 (14.3%) 11 (44.0%) 16 (39.0%) 0.357
Lymphocytic infiltration 53 5 (71.4%) 17 (68.0%) 31 (75.6%) 0.796
Granulation tissue proliferation 49 3 (42.9%) 19 (76.0%) 27 (65.9) 0.248
Vascular invasion 10 0 (0.0%) 4 (16.0%) 6 (14.6%) 0.534
Perineuronal invasion 5 1 (14.3%) 1 (4.0%) 3 (7.3%) 0.625
Expression of myoepithelial markers 43 4 (57.1%) 19 (76.0%) 20 (48.8%) 0.092
Expression of basal-like markers 52 5 (71.4%) 22 (88.0%) 25 (61.0%) 0.063
Molecular classification Basal-like subtype 37 3 (42.9%) 9 (36.0%) 25 (61.0%) 0.132
Luminal A 20 3 (42.9%) 9 (36.0%) 8 (19.5%) 0.217
Luminal B 7 1 (14.3%) 5 (20.0%) 1 (2.4%) 0.057
HER2-overexpressing 6 0 (0.0%) 0 (0.0%) 6 (14.6%) 0.078
Null subtype 3 0 (0.0%) 1 (4.0%) 2 (4.9%) 0.834
Disease progression 11 1 (14.3%) 2 (8.0%) 8 (19.5%) 0.796
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of the necrotic zone (P > 0.05) (Table 2). Regarding molecu-
lar typing, 37 cases (50.7%) of CNC were basal-like subtype,
while luminal A, luminal B, HER2-overexpressing, and null
subtype accounted for 20 (27.4%), seven (9.6%), six (8.2%)
and three cases (4%), respectively. There was no significant
association between the molecular classification of CNC
and the relative size of the necrotic zone (P > 0.05)
(Table 2).Figure 4 Immunohistochemical findings of CNC. (a): The tumor cells were
diffusely, strongly-positive for EGFR (×10). (c): The tumor cells were positiveDiscussion
CNC has recently been described as a breast tumor sub-
type, but has not yet been recognized by WHO. In 1997,
Hasebe et al. [1] first reported a series of patients with
“fibrotic focus in invasive ductal carcinoma of the
breast”. In 1999, Tsuda et al. [2] reported on a series
with high-grade IDCs with large central acellular zones.
They noted that these tumors carried high risks of me-
tastasis and death. In 2001, Jimenez et al. [4] reported adiffusely, strongly-positive for CK5/6 (×10). (b): The tumor cells were
for CD10 (×10).
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“centrally necrotizing carcinomas of the breast”. How-
ever, the largest of these reports only accounted for 34
cases. In the present study, we investigated 73 cases of
CNC, which represents the largest series to date.
Clinical manifestations
CNC accounts for 2%–3% of all breast cancers and oc-
curs predominantly in middle-aged and older women
[3]. The age of onset ranged from 30–80 years, with an
average age of 51.8 years [3]. All patients in the current
study were female, ranging in age from 34 to 80 years
(mean age, 51.8 years), accounting for 2.7% of all breast
carcinomas at our hospital during the study period, and
consistent with previous reports. In our study, the clin-
ical genetic testing or strong family history were not
available, so BRCA1 mutation status was unknown for
these cases and further research is needed. Jimenez et al.
[4] reported that most cases were T1 or T2 tumors, and
72% were node-negative and only 28% had lymph node
metastases, all fewer than four. In the current study,
64.5% (40/62) of patients were axillary node negative
and 35.5% (22/62) had axillary lymph node metastases
(mean, 5.8) which were in accordance with what was
previously published. However, Tsuda et al. [3] found
few lymph node-negative patients, and lymph node me-
tastases were detected in 55% of patients, with a mean
of 7.20. Reports on the radiographic features are scarce.
In our study, ultrasonography was performed in 26
patients, usually presented with well-defined, heteroge-
neous, hypoechoic lesions. Oda et al. [7] reported a well-
circumscribed tumor with cystic and solid parts and an
abundant blood supply, similar to some in the present
series, and noted that preoperative diagnosis was im-
portant for breast surgeons and radiologists because of
the suspected risk of hemorrhage in these lesions.
Hemanz et al. [5] reported one case of CNC in which it
was not possible to obtain a sample of viable tumor cells
despite numerous biopsies, because of the minimal
width of the viable tumor rim and the predominance of
fibrosis and adiponecrosis in the central region. In our
study, two cases could not be diagnosed as breast carcin-
oma by needle core biopsy, but were subsequently diag-
nosed after complete tumor resection. We therefore
recommend open biopsy in those cases suspicious for
CNC with an inconclusive needle core biopsy, to avoid
misdiagnosis.
Pathological features
Yu et al. [6] reported well-circumscribed, nodular
masses with a cut surface with a moderate or soft
consistency and white to tan appearance, ranging in size
from 1.0–5.0 cm (mean, 2.5 cm). In our study, 91.8%
(59/73) of tumors were unicentric, well-defined noduleswith pushing borders, ranging from 1.0–6.5 cm (mean,
2.49 cm). The cut surface was usually moderate to hard,
gray, sallow, or reddish-brown, with necrosis or cystic
degeneration in the central region, similar to the report
of Yu et al. [6]. Infiltrative edge was only detected in 14
cases (19.2%) in our series, which was similar to that re-
ported by Tsuda et al. [3].
Microscopically, the tumors demonstrated extensive
central necrosis with varying levels of fibrotic or hyalinized
matrix, surrounded by a ring of remaining tumor tissue.
The transition between the central necrotic zone and the
viable tumor tissue was usually abrupt, with no granula-
tion tissue or collagen. These represented the most char-
acteristic histological manifestations of CNC [4]. The
central necrotic zone usually accounted for >70% of the
tumor size, but only >30% in a few cases. The central nec-
rotic or acellular zone showed three different morpho-
logical manifestations as described above, characterized
by: (i) coagulative necrosis; (ii) fibrotic, hyaline material or
scar tissue; and (iii) infarction. In our study, 63.4% of pa-
tients showed coagulative necrosis (47 cases), which was
similar to the 68.6% reported by Yu et al. [6]. The mor-
phological manifestations of the necrosis was also similar
in both studies. The viable tumor tissue surrounding the
central necrotic zone was poorly differentiated, being
mostly IDC grade 3, with several cases of IDC grade 2 [6].
The periphery of the CNCs was usually associated with a
variable ductal carcinoma in situ component [2]. Jimenez
et al. [4] detected ductal carcinoma in situ in 19 cases
(55.9%). In our series, IDC grade 3 was detected in 67
cases (91.8%), with ductal carcinoma in situ in 36 cases,
similar to the findings of Jimenez et al. [4]. However, it is
worth noting that some unusual histologic types of viable
tumor tissue were also detected in our study, including in-
vasive micropapillary carcinoma in two cases (first re-
ported by Yu et al. [6]), intraductal papillary carcinoma in
one case, and mucinous carcinoma in five cases (not pre-
viously described). Several cases have been accompanied
by squamous metaplasia or spindle cell differentiation
[3-5]. In this study, squamous metaplasia was present in
four cases, spindle cell differentiation in one, and cartil-
aginous metaplasia in one (had not been published in the
literature). However, differences in terms of the lympho-
cytic infiltrates and myxoid matrix which usually consid-
ered to be from myoepithelial cells of the breast [12,13]
have been reported. Tsuda et al. [3] found that the cen-
tral zone of most tumors was accompanied by a myxoid
matrix, while only eight cases (24.2%) reported by Yu
et al. displayed this feature [6], and 54.5% of cases were
accompanied by lymphocytic infiltrates. However, per-
ipheral lymphocytic infiltrates were rare in Jimenez
et al.’s study [4]. In the present study, 38.4% of tumors
displayed myxoid matrix and 72.6% showed peripheral
lymphocytic infiltrates. Furthermore, 67.1% of cases
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periphery of the tumor, representing the first report of
this feature.
CNC comprises an extensive central necrotic or acellular
zone, but the definition of what proportion of the tumor
area qualifies as “large” remains controversial. Tsuda et al.
[3] considered that a central infarction occupying >30% was
a large central acellular zone, while Jimenez et al. [4] sug-
gested that the central necrotic or acellular zone should ac-
count for ≥70% of the cross-sectional area of the tumor. In
the present study, the necrotic zone accounted for >30% of
the cross-sectional area in all cases, and >70% in 41 cases
(56.2%). However, there was no significant relationship be-
tween clinicopathological features and size of the necrotic
zone (P > 0.05), suggesting that a central acellular zone ac-
counting for >30% of the tumor provided an appropriate
definition of CNC. However, other features should also be
taken into consideration, including the characteristic histo-
logical manifestation of the extensive central necrotic or
acellular zone surrounded by a ring of remaining tumor tis-
sue. The pathogenesis of the central necrotic zone remains
unclear. Jimenez et al. [4] suggested that rapid centrifugal
growth with insufficient vascularization resulted in infarc-
tion. Proliferation of viable tumor cells (Ki-67 > 50% in
84.9% of CNCs and >70% in 58.8% in the present study),
the myxoid matrix, and limitation and expansion of the sur-
rounding granuloma may all contribute to the development
of the central necrotic zone.
Although CNC was associated with a high rate of dis-
tant metastases, lymph node metastasis and vascular in-
vasion were uncommon. Jimenez et al. [4] found that
72% of cases were node-negative, and vascular invasion
only occurred in two cases (5.9%). Yu et al. [6] reported
negative lymph node metastasis in 17 cases (58.6%) and
vascular invasion in seven. In accordance with those
studies, we found negative lymph nodes in 40 cases
(64.5%) and vascular invasion in 10 (13.7%). However, in
the present study, 67.1% of cases were accompanied by
granulomatous reactions at the periphery of the tumor
in which there were the regeneration of considerable ca-
pillary vessels and indicated that the newborn capillaries
might supply nutrition for tumors as well as increased
the risk of a blood metastasize.
Immunophenotype
The immunophenotypic characteristics of CNC are un-
clear, including the expression patterns of ER, PR and
HER2, and of basal-like and myoepithelial markers. The
relationship between CNC and basal-like breast carcin-
oma is also uncertain. Tsuda et al. [3] reported that 85%
of the tumors expressed myoepithelial markers (expres-
sion of ≥1 myoepithelial markers, including S100-α,
S100-β, α-SMA and CK14), and speculated that the tu-
mors might be derived from myoepithelial cells orundergo myoepithelial differentiation. Yu et al. [6] spec-
ulated that CNC might originate from basal-like cells
and represent a basal-like breast carcinoma, because of
the higher expression of basal-like markers (87.9%) and
the fact that myoepithelial markers were often (46.2%)
simultaneously positive for basal-like markers. Our study
found higher expression of basal-like markers (72.2%)
than myoepithelial markers (60.6%), but both were
expressed more in CNCs than in controls. According to
the molecular classification, more than half the CNCs
(50.7%) were basal-like breast carcinomas, followed by
luminal-A tumors (27.4%). These results were compar-
able to those of Yu et al. [6], supporting the idea that
the tumors might be derived from basal-like cells or
undergo basal-like differentiation. Although most CNCs
were basal-like according to molecular-typing methods,
further studies are needed to determine whether or not
they should be included in basal-like breast cancer.
Prognosis
CNC is characterized by aggressive behavior and a poor
prognosis, with high rates of distant metastasis and mor-
tality. Tsuda et al. [3] reported 20 cases of high-grade
IDC with large, central acellular zones, compared with
controls without these zones, and found that the rates of
lung metastasis (65%) and brain metastasis (30%), as well
as mortality, were higher than those in controls. Jimenez
et al. [4] reported an OS of only 22.5 months in 34 pa-
tients with CNC, and of 20 patients with metastases, 15
developed lung and central nervous system metastases.
In the present study, follow-up data were available for
28 patients. Disease progression occured in 11 patients,
and by the last follow-up, one patient had died of breast
carcinoma. The prognosis was poorer than in the 11
controls with follow-up data, who showed no local re-
currence or metastasis. As well all know, necrosis and
nodal status are ralated to the prognosis of breast cancer
patients [14-17], but the independent risk factors for
CNC remain controversial. Tsuda et al. [3] demonstrated
that nodal status and a large, central acellular zone were
independent prognostic factors for metastasis and death,
and noted that the central acellular zone was a single in-
dicator of a high risk of brain metastasis. Meanwhile,
Jimenez et al. [4] noted that nodal status was not associ-
ated with survival but larger tumour size with poor
prognosis. The present study showed that CNCs with
necrotic zones accounting for >70% of the tumor had
higher recurrence and metastasis rates than tumors in
which the necrotic zone occupied >30% but <70% of the
tumor, though the results were not significant. These re-
sults suggest that the size of the zone central necrotic or
acellular zone should not be considered as an independ-
ent prognostic factor. However, the follow-up data were
limited, and further studies involving more cases and
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pendent prognostic factors in CNC.
To summarize, CNC is characterized by the following
features. (i) The tumors are usually well-defined, uni-
centric nodules with necrosis or cystic degeneration in
the central region. (ii) Microscopically, the tumors com-
prise extensive central necrotic or acellular zones that
account for ≥30% of the cross-sectional area of the
tumor, surrounded by a rim of viable tumor cells, which
are mostly high-grade IDCs. The transition between the
central necrotic or acellular zone and viable tumor tissue
is usually abrupt and the peripheral interstitium usually
includes lymphocytic infiltrates and myxoid matrix. (iii)
Proliferating granulation is usually present at the periph-
ery of the tumor. (iv) Most tumor cells that demonstrate
high proliferative activity express basal-like markers, and
most tumors were basal-like breast cancer. (v) The age
of onset was older and patients showed rapid clinical
progression and a poor prognosis with high rates of re-
currence and a tendency to develop lung and brain
metastases.
Conclusions
CNC represents a rare, novel subtype of breast carcin-
oma. It is associated with distinctive clinicopathologic
features mostly characterized as basal-like type. Its high
proliferative activity, highly-aggressive biological behav-
ior, and high rates of recurrence and metastasis, suggest
that CNC should be classified as a new type of breast
carcinoma. Increasing awareness of this new type breast
carcinoma will help to improve its diagnosis and
therapy.
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